PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers
Status:
Completed
Trial end date:
2019-09-15
Target enrollment:
Participant gender:
Summary
This is a first-in-human (FIH) study to explore the safety, tolerability and pharmacokinetics
of PA after oral ascending dose administration to healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Scientific Center for Anti-infectious Drugs, Kazakhstan
Collaborators:
Al-Farabi Kazakh National University (KazNU) Institute Of Cardiology & Internal Diseases, Kazakhstan